Transforming Nordic Healthtech: Novo and EIFO Deploy €48m to Boost Swedish HealthCap's Newest Fund

Published: 24 Apr 2025
HealthCap secures a hefty €48m investment from Novo Holdings and EIFO, paving the way for further boosting the Nordic healthtech scene.

In a major show of confidence for the Nordic healthtech ecosystem, investment giants Novo Holdings and EIFO are fuelling Swedish HealthCap’s latest fund to the tune of €48 million. The infusion of such a significant amount of capital is set to catalyse a transformative progression in healthcare technology across the region.

Both Novo Holdings and EIFO have a track record of backing innovative technological initiatives. This move reaffirms their commitment to fostering an environment where cutting-edge healthtech solutions can thrive. By backing HealthCap – a famous investment beacon in the health sector – they’re opening up new avenues for entrepreneurs and researchers who are keen to make waves in the health industry.

On a broader scale, this deal accentuates the growing influence Nordic countries are exerting on the global technological landscape. It’s a reminder that Scandinavia isn’t just about beautiful landscapes and Vikings; it’s also a hotbed of innovation, full of burgeoning tech companies setting global trends.

The stakes may be high, but so is the confidence in the potential of Nordic health technology. As this investment shows, the region’s healthtech startups have every reason to look forward to a future bright with opportunity, innovation and growth. We’re just as excited to see what this funding will bring forth in the Scandinavian health tech ecosystem!